Aurora Cannabis (ACB) Return on Capital Employed (2019 - 2026)
Aurora Cannabis (ACB) posted quarterly Return on Capital Employed of 4.19% for Q1 2026, up 283.0% year-on-year from 1.09% in Q1 2025, and up 208.72% on a QoQ basis from 1.36% in Q1 2025.
Aurora Cannabis (ACB) Return on Capital Employed (2019 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Return on Capital Employed for 7 consecutive years, with 4.19% the latest figure, recorded in Q1 2026.
- Quarterly Return on Capital Employed rose 283.0% year-over-year to 4.19% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.19% (up 283.0% YoY) and the FY2026 annual result came in at 7.1%, down 776.0% from the prior year.
- Return on Capital Employed grew to 4.19% in Q1 2026 per ACB's latest filing, from 1.36% in the prior quarter.
- Over the last five years, Return on Capital Employed for ACB reached as high as 4.19% in Q1 2026 and fell as low as 921.82% in Q1 2024.
- A 4-year average of 233.84% and a median of 8.86% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 844 bps — and 2025, when it jumped 92317 bps.
- Year by year, Return on Capital Employed stood at 19.08% in 2022, then plunged by 4732 bps to 921.82% in 2024, then surged by 100 bps to 1.36% in 2025, then surged by 209 bps to 4.19% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 4.19%, 1.36%, and 921.82% for Q1 2026, Q1 2025, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 4.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.19% |
| Mar 31, 2025 | 1.36% |
| Mar 31, 2024 | -921.82% |
| Jun 30, 2022 | -19.08% |
| Jun 30, 2021 | -10.64% |
| Jun 30, 2020 | -17.59% |
| Jun 30, 2019 | -6.15% |